
Spotify Founder Brings $700M Body Scan Startup to America
Spotify founder Daniel Ek is expanding his medical imaging startup Neko Health into the United States after securing a massive funding round to deliver consumer-focused preventative testing.
Inioluwa Ademidun | 3 Oct. 2026 · 6 min read

The preventative medical sector continues drawing technology founders equipped with massive capital reserves. Daniel Ek, the billionaire who built the Spotify music empire, is bringing his medical imaging venture Neko Health to North America. After establishing a highly successful operating model across Sweden and the United Kingdom, the enterprise is opening physical clinics in New York. The company secured a $700M Series C funding round to finance this ambitious physical expansion, valuing the corporate entity near $7B. The cash allows the firm to lease expensive retail real estate in Manhattan and purchase heavy diagnostic equipment without worrying about immediate profitability.
For $500 out of pocket, a patient receives a one-hour appointment that differs entirely from a standard medical physical. The hardware uses dozens of high-resolution cameras to photograph every inch of the skin, searching for unusual moles or hidden dermatological threats. Alongside the visual mapping, medical staff draw blood to test 55 distinct biomarkers. This laboratory analysis evaluates metabolic function, cardiovascular risks, and unseen internal inflammation. The entire process is designed to catch silent conditions before they become terminal diseases. Financing physical medical facilities across the United States requires enormous capital, a reality that mirrors the heavy hardware costs we documented when Crusoe secured a $3B funding round at a $30B valuation for physical data centers.
Applying Software Principles to Human Biology
The involvement of a music streaming billionaire brings a unique software mentality to the medical field. Ek spent over a decade building algorithms that recommend songs based on user listening habits. He is now attempting to apply that same data-heavy approach to human biology. By treating the human body as a collection of measurable data points, the engineering team believes software can recognize patterns of disease far earlier than a human doctor. This transition from consumer entertainment to deep medical technology highlights how Silicon Valley leaders are searching for harder physical problems to solve.
Manufacturing the physical scanning pods adds another layer of operational friction. The company cannot simply order these specialized diagnostic machines from a generic medical catalog. Engineers must design custom hardware that synchronizes dozens of optical sensors, thermal cameras, and biometric readers into a single unified booth. Producing these machines in large quantities requires a dependable supply chain for specialized lenses and silicon chips. Any delay in manufacturing these booths directly limits how quickly the company can open new retail locations.
Designing a Premium Patient Experience
To convince people to voluntarily undergo medical testing, the founders had to rethink clinic architecture completely. Most traditional hospitals feel sterile, cold, and intimidating. The startup decided to borrow interior design concepts from luxury retail spaces and high-end hospitality venues. Patients wait in rooms decorated with natural wood finishes and soft pastel colors.
The actual scanning chambers use programmable lighting systems that adjust to create a calming atmosphere. By removing the clinical anxiety usually associated with blood tests, the company hopes to convince consumers to return every single year for recurring checkups. If the environment feels like a premium spa appointment rather than a stressful hospital visit, customer retention rates remain high. A recurring annual subscription model for bodily health generates dependable revenue for the corporate balance sheet.
The Rising Demand for Out of Pocket Health Data
Consumer demand for personalized medical data is growing rapidly. The company claims a global waiting list exceeding 300,000 names, with over 25,000 New York residents registering before the first clinic even opened its doors. Americans are increasingly willing to bypass their insurance providers and pay cash directly for medical insights. Standard health insurance policies usually refuse to cover comprehensive preventative scans unless a doctor already suspects a specific illness. This friction between preventative testing and standard coverage networks matches issues we covered when Corridor secured $25M to fix small business health insurance.
Because patients want to catch diseases before symptoms appear, they gladly pay $500 for peace of mind. Wealthy consumers want total control over their health records. By combining rapid blood analysis with full body surface imaging, Ek and his team are trying to intercept medical issues early. If the business model succeeds in New York, the company plans to quickly expand operations into wealthy suburban neighborhoods across the country.
Skepticism From the Medical Establishment
Despite the massive consumer interest, traditional medical professionals remain highly skeptical of commercial whole body scanning. Doctors warn that aggressively testing healthy people without any symptoms frequently leads to false positives. When a sensitive imaging machine flags a completely harmless cyst or a minor tissue shadow, the patient often panics.
They immediately rush to their primary care physician demanding expensive follow up MRIs, invasive biopsies, and specialist consultations. These unnecessary procedures place heavy strain on an already overburdened medical system. Critics argue that hunting for hidden problems often causes more physical harm and emotional distress than simply waiting for actual symptoms to emerge.
The leadership team dismisses these concerns by pointing to their European operational history. The clinics in Stockholm and London have successfully processed tens of thousands of patients over the past several years. Management insists the proprietary software filtering system accurately separates genuine medical threats from harmless bodily quirks. By catching cardiovascular conditions and aggressive skin cancers early, the startup argues it ultimately saves the medical system money by avoiding expensive late stage emergency room treatments.
Navigating Strict Patient Privacy Laws
Handling gigabytes of highly sensitive biological data introduces intense privacy concerns. When a patient steps into the scanning chamber, the machines capture high resolution photographs of their naked body and compile a permanent digital record of their blood chemistry. Protecting this information from external hackers is a massive technical obligation.
The enterprise must comply strictly with the Health Insurance Portability and Accountability Act in the United States, meaning all server storage requires heavy encryption. If a cybercriminal breaches the corporate database, the stolen information would expose the most intimate health details of wealthy politicians, corporate executives, and everyday citizens. Protecting consumer identity records against targeted social engineering attacks is increasingly difficult, a reality we explored when covering the Revolut data breach involving fake government requests.
Bringing a European medical startup into the highly regulated American healthcare sector presents unique legal challenges. State medical boards closely monitor private diagnostic centers to ensure they do not offer unlicensed medical advice. The company carefully positions its service as a wellness data tool rather than a definitive diagnostic replacement for a licensed doctor. The final scan report provides statistical probabilities and flags areas requiring professional review, forcing the patient to consult a traditional doctor for an official diagnosis. The success of this physical expansion will test whether affluent urban consumers view medical scanning as a luxury subscription or a medical necessity. Changing how people interact with their own biology is an expensive gamble. With nearly $1B in total venture capital backing their vision, the team has exactly enough money to find out if the American public agrees.
Read More on TechRobust:

Inioluwa Ademidun
Inioluwa Ademidun
Expertise:African Tech Ecosystem, Early-Stage Startups, Emerging Market Dynamics, Venture Capital & Tech Reporting, Product Management
Award:TechRobust Contributor of the Year 2025
Inioluwa is a Senior Product Manager by day and an investigative technology reporter by night, bridging the gap between scalable software architecture and high-impact journalism. She delivers deep-dive analysis on venture-backed founders, regulatory shifts, and grassroots tech ecosystems across Africa and global emerging markets.